Patents
Patents for C07D 241 - Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings (18,673)
10/2002
10/10/2002WO2002079172A1 Method for preparing monocyclic $i(n)-acyl-aminolactam compounds and combinatorial libraries thereof
10/10/2002WO2002079171A1 Process for the enhancement of cycle life of a zink-chromium based catalyst
10/10/2002WO2002078744A1 Remedies for psychoneurosis
10/10/2002WO2002078708A1 Hiv inhibiting pyrazinone derivatives
10/10/2002WO2001072728A9 Novel piperazine derivatives
10/10/2002US20020147336 Glucocorticoid receptor modulators
10/10/2002US20020147230 Cardiovascular disorders; antihistamines
10/10/2002US20020147200 Central nervous system disorders; antiserotonine agents
10/10/2002US20020147194 Psychological disorders; antiserotonin agents; headache therapy
10/09/2002EP1144498B1 Flame retardant polymer blends, and method for making
10/09/2002CN1373754A Antibacterial agents
10/09/2002CN1092181C Benzyloxy substd, aromatics and their use as fungicides and insecticides
10/08/2002USRE37873 Phenylacetic acid derivatives, preparation thereof and intermediates therefor, and compositions containing them
10/08/2002US6462076 Beta-amino acid nitrile derivatives as cathepsin K inhibitors
10/08/2002US6462046 Non-thiazolidinedione ppargamma agonists; useful in modulation of blood glucose and the increase of insulin sensitivity in mammals
10/03/2002WO2002076988A2 Tert. alkylphenoxy substituted polycyclic compounds
10/03/2002WO2002076947A1 Mch antagonists and their use in the treatment of obesity
10/03/2002WO2002076939A2 Cysteine protease inhibitors
10/03/2002WO2002076925A2 Non-imidazole aryl alkylamines compounds as histamine h3 receptor antagonists, preparation and therapeutic uses
10/03/2002WO2002076177A2 Design and synthesis of optimized ligands for ppar
10/03/2002WO2002059127A3 Pyrazinoquinoxaline derivatives as serotonin agonists and antagonists
10/03/2002US20020143180 Reacting ethylenediamine and propyleneglycol in a fixed bed reactor over a zinc-chromium based catalyst, at a temperature in the range of 300-409 degrees C., the temperature of reaction being increased step wise dependant on reaction
10/03/2002US20020143034 Aminoalcohol derivatives and their use as beta 3 adrenergic agonists
10/03/2002US20020143020 Novel piperazine derivatives
10/03/2002US20020142969 Using didepsipeptide for the control of endoparasites in medicine and veterinary medicine
10/03/2002US20020141032 Controlled diffusion coefficient electrochromic materials for use in electrochromic mediums and associated electrochromic devices
10/03/2002CA2441080A1 Non-imidazole aryl alkylamines compounds as histamine h3 receptor antagonists, preparation and therapeutic uses
10/02/2002EP1244638A2 Phenanthryl piperazinyl dicarboxylic acids as selective nmda receptor modulating agents
10/02/2002CN1372553A Novel thiazine or pyrazine derivatives
10/02/2002CN1091766C Prenyl transferase inhibitors
10/01/2002US6458998 Naphthaleneureas as antidiabetic agents
10/01/2002US6458794 Potassium channel inhibitors
10/01/2002CA2228370C Piperazino derivatives as neurokinin antagonists
09/2002
09/26/2002WO2002074735A2 Biurethane derivatives
09/26/2002WO2002074267A1 Novel dyeing compositions for the dyeing of keratin fibres comprising 6-membered heterocyclic hydrazone compounds as an oxidation base
09/26/2002WO2002024636A3 N-acylsulfonamide apoptosis promoters
09/26/2002US20020137939 Novel guanidinobenzamides
09/26/2002DE10113402A1 New N,N'-bis-(Aminocarbonyl)-hydrazine derivatives are Factor Xa and Factor VIIa inhibitors useful e.g. for treating thrombosis, myocardial infarction, inflammation, apoplexy, restenosis or tumors
09/26/2002CA2441427A1 Biurethane derivatives
09/25/2002EP1242427A1 Novel piperidine and piperazine derivatives
09/25/2002EP1181279A4 Diketodiazacyclic compounds, diazacyclic compounds and combinatorial libraries thereof
09/25/2002EP0912534B1 Muscarinic antagonists
09/24/2002US6456418 Flexible electrochromic devices
09/24/2002US6455698 Conformationally semi-constrained quinoxaline 2,3-diones as neuroprotective agents
09/24/2002US6455520 Benzamide derivatives and their use as cytokine inhibitors
09/19/2002WO2002072559A1 Process to intermediates for biologically active compounds
09/19/2002WO2002072091A1 Anticancer drug-tolerance inhibitors
09/19/2002WO2002029021A3 Biotechnological method for preparing carboxylic acids with a hydroxy-nitrogen heterocycle
09/19/2002US20020132853 Diaryl piperazines and related compounds useful in the treatment of a chronic and acute pain conditions, itch and urinary incontinence.
09/19/2002US20020132810 Novel heterocyclic amide derivatives
09/19/2002US20020131932 Radiopharmaceuticals for diagnosing alzheimer's disease
09/19/2002DE10130835A1 Diphenyl-Derivate Diphenyl derivatives
09/18/2002EP1240148A1 Benzo[a]phenazin-11-carboxamide derivatives and their use as joint inhibitors of topomerase i and ii
09/18/2002EP1240147A1 Potassium channel inhibitors
09/18/2002EP1240143A1 New modulators of dopamine neurotransmission
09/18/2002EP1095029B1 Piperazine derivatives inhibiting human immunodeficiency virus replication
09/18/2002EP0888322B1 Electrophilic ketones for the treatment of herpesvirus infections
09/18/2002EP0865424B1 Pesticides
09/18/2002EP0680955B1 PROCESS FOR PRODUCING N-tert-BUTYL-2-PYRAZINECARBOXAMIDE AND N-tert-BUTYL-2-PIPERAZINECARBOXAMIDE
09/17/2002US6451803 N-acyl and n-aroyl aralkyl amides useful in treating seritonergic disorders
09/17/2002US6451798 Substituted alkyl piperazine derivatives
09/17/2002US6451792 Matrix metalloprotease inhibitors
09/17/2002US6451791 Amidoaromatic ring sulfonamide hydroxamic acid compounds
09/17/2002CA2057338C Diarylfluoromethane compounds
09/12/2002WO2002070541A2 Peptide deformylase inhibitors
09/12/2002WO2002070509A2 Antagonists of mcp-1 function and methods of use thereof
09/12/2002WO2002070494A1 Aryl and heteroaryl urea chk1 inhibitors for use as radiosensitizers and chamosensitizers
09/12/2002WO2002070493A1 Bisaryl derivatives having fsh receptor modulatory activity
09/12/2002WO2002069895A2 Heterocyclic analgesic compounds and methods of use thereof
09/12/2002WO2001012600A9 INHIBITORS OF FACTOR Xa
09/12/2002US20020128270 Treating stroke, arhtritis, cancer, tissue ulceration, decubitis ulcer, restenosis, periodontal disease, epidermolysis bullosa, scleritis, psoriasis, AIDS, sepsis, and septic shock.
09/12/2002US20020128255 Substituted hydroxyl amine derivatives; inhibitors of beta-secretase, inhibit beta-secretase-mediated cleavage, inhibitors of A beta production, and/or are effective to reduce amyloid beta deposits or plaques
09/12/2002US20020127202 Compounds and compositions for delivering active agents
09/12/2002CA2439849A1 Antagonists of mcp-1 function and methods of use thereof
09/12/2002CA2439827A1 Peptide deformylase inhibitors
09/12/2002CA2434184A1 Bisaryl derivatives having fsh receptor modulatory activity
09/11/2002EP1237880A2 Pyrazine based inhibitors of glycogen synthase kinase 3
09/11/2002EP1237849A1 Activators of soluble guanylate cyclase
09/11/2002CN1368892A Sustained release formulation of peptide
09/11/2002CN1090622C Process for producing 6-substituted 2(1H)-quinoxalinone
09/10/2002US6448408 Process for the preparation of heteroaryl-phenylalanines
09/10/2002US6448248 Heterocyclic carboxylic acid derivatives, the production and use thereof as endothelin receptor antagonists
09/10/2002CA2195129C Substituted piperidine intermediates for producing heterocyclic-cyclic amine derivatives capable of inhibiting cholinesterase
09/06/2002WO2002068399A1 Aryl carbamate derivatives, preparation and use thereof
09/06/2002WO2002068380A1 Synthetic excitatory amino acids
09/06/2002WO2002068367A1 A method to inhibit ethylene responses in plants
09/06/2002WO2002067866A2 Piperazine derivatives as metalloprotease inhibitors
09/06/2002WO2002030405A3 Treatment of affective disorders by the combined action of a nicotinic receptor agonist and a monoaminergic substance
09/06/2002WO2001090071A3 Substituted iminoazines used as herbicides
09/06/2002CA2438828A1 Aryl carbamate derivatives, preparation and use thereof
09/05/2002US20020123633 Reacting an alpha -picoline or gamma -picoline with formaldehyde in vapor phase in presence of metal cation modified zeolite MFI or zeolite zeolite MEL to produce 2-vinylpyridine or 4-vinylpyridine compound
09/05/2002US20020123502 5-(4-(2-(2,4-dimethyl-6-oxo-1,6-dihydro-1-pyrimidinyl) -ethoxy)phenyl methyl)thiazolidine-2,4-dione for example; also oxazolidine-2,4-dione, and 1,2,4-oxadiazolidine-3,5-dione derivatives; reducing blood glucose levels
09/04/2002EP0934278B1 Bis(acridinecarboxamide) and bis(phenazinecarboxamide) as antitumour agents
09/04/2002EP0929525B1 Heteroaryloxyethylamines as 5-ht1a receptor ligands
09/04/2002EP0832074B1 Amino acid derivatives of substituted quinoxaline 2,3-dione derivatives as glutamate receptor antagonists
09/04/2002EP0830348B1 Cyclic amine derivatives of substituted quinoxaline 2,3-diones as glutamate receptor antagonists
09/04/2002CN1090187C HIV protease inhibitors in pharmaceutical combinations for treatment of AIDS
09/04/2002CN1090186C HIV protease inhibitors in pharmaceutical combinations for treatment of AIDS
09/03/2002US6444817 Anticoagulants
09/03/2002US6444815 Method for producing heteroaromatic aldehydes